SCHEMBL200090

SCHEMBL200090

CC(=O)OC1CCCCCC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.52
NAAA Q02083 2/20 0.47
HTT P42858 1/20 0.46
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
CYP2C19 P33261 1/20 0.44
CYP19A1 P11511 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
CHRM2 P08172 3/20 0.38
CHRM4 P08173 3/20 0.38
CHRM1 P11229 3/20 0.38
CHRM3 P20309 3/20 0.38
CHRM5 P08912 2/20 0.38
MMP1 P03956 1/20 0.38
MMP9 P14780 1/20 0.38
MMP12 P39900 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31570134 1.00 EPHX1 (0.52) EPHX1NAAAHTTCA12CA1
SCHEMBL11098598 1.00 EPHX1 (0.52) EPHX1NAAAHTTCA12CA1
SCHEMBL1695496 1.00 EPHX1 (0.52) EPHX1NAAAHTTCA12CA1
SCHEMBL5167284 1.00 EPHX1 (0.52) EPHX1NAAAHTTCA12CA1
SCHEMBL23018499 1.00 EPHX1 (0.52) EPHX1NAAAHTTCA12CA1
SCHEMBL23506964 1.00 EPHX1 (0.52) EPHX1NAAAHTTCA12CA1
SCHEMBL19063411 1.00 EPHX1 (0.52) EPHX1NAAAHTTCA12CA1
SCHEMBL93396 1.00 EPHX1 (0.52) EPHX1NAAAHTTCA12CA1
SCHEMBL22540554 1.00 EPHX1 (0.52) EPHX1NAAAHTTCA12CA1
SCHEMBL30601812 1.00 EPHX1 (0.52) EPHX1NAAAHTTCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023188830-A1 LIPID NANOPARTICLES 国立大学法人北海道大学 2023-10-05 WO claimed
US-10890847-B2 Pattern forming method, resist pattern, method for manufacturing electronic device, and electronic device FUJIFILM CORPORATION (JP) 2021-01-12 US claimed
EP-2275398-B1 APPLICATION OF AN IRIDIUM COMPLEX IN ASYMMETRIC CATALYTIC HYDROGENATION OF AN UNSATURATED CARBOXYLIC ACID ZHEJIANG JIUZHOU PHARM CO LTD (CN) 2016-05-04 EP claimed
CN-104945309-A Novel nitroso compounds as nitroxyl donors and methods of use thereof CARDIOXYL PHARMACEUTICALS INC 2015-09-30 CN claimed
EP-2272853-B1 SPIRO PHOSPHORUS-OXAZOLINE, SYNTHESIS AND USE THEREOF ZHEJIANG JIUZHOU PHARM CO LTD (CN) 2014-08-27 EP claimed
US-8450493-B2 Spiro phosphine-oxazoline, preparation method and application thereof Zheijiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2013-05-28 US claimed
US-20110118472-A1 Spiro Phosphine-Oxazoline, Preparation Method and Application thereof Zheijiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-05-19 US claimed
US-20110092732-A1 APPLICATION OF IRIDIUM COMPLEXES IN ASYMMETRIC CATALYTIC HYDROGENATION OF UNSATURATED CARBOXYLIC ACIDS Zheijiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-04-21 US claimed
EP-2275398-A1 APPLICATION OF THE IRIDIUM COMPLEX IN ASYMMETRIC CATALYTIC HYDROGENATION FOR UNSATURATED CARBOXYLIC ACID Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-01-19 EP claimed
EP-2272853-A1 SPIRO PHOSPHORUS-OXAZOLINE, SYNTHESIS AND USE THEREOF Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-01-12 EP claimed
US-12578648-B2 Rinsing liquid and pattern forming method FUJIFILM CORPORATION (JP) 2026-03-17 US disclosed
EP-3435158-B1 ACTIVE RAY-SENSITIVE OR RADIATION-SENSITIVE COMPOSITION, METHOD FOR PURIFYING ACTIVE RAY-SENSITIVE OR RADIATION-SENSITIVE COMPOSITION, PATTERN-FORMING METHOD, AND METHOD FOR PRODUCING ELECTRONIC DEVICE FUJIFILM CORP (JP) 2025-11-19 EP disclosed
US-12386265-B2 Pattern forming method and method for manufacturing electronic device FUJIFILM CORPORATION (JP) 2025-08-12 US disclosed
US-20250205362-A1 LIPID NANOPARTICLES NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2025-06-26 US disclosed
US-12306538-B2 Treatment liquid and pattern forming method FUJIFILM CORPORATION (JP) 2025-05-20 US disclosed
WO-1991013089-A1 PEPTIDE DERIVATIVES AND PRODUCTION THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1991-09-05 WO disclosed
US-4225513-A OF SECONDARY ALCOHOLS TO FORM KETONES UNION CARBIDE CORPORATION (US) 1980-09-30 US disclosed
US-4112235-A Transesterification of carboxylic acids UOP INC. (US) 1978-09-05 US disclosed
US-4093661-A METAL OXIDE CATALYSTS, PRODUCING ALDEHYDES OR KETONES UNION CARBIDE CORPORATION (US) 1978-06-06 US disclosed
US-4088820-A Transesterification of olefins UOP INC. (US) 1978-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250205362-A1 LIPID NANOPARTICLES ECH1, C1R, SGMS1 EPHX1 65/4885NAAA 1627/4885HTT 3163/4885
US-20110092732-A1 APPLICATION OF IRIDIUM COMPLEXES IN ASYMMETRIC CATALYTIC HYDROGENATION OF UNSATURATED CARBOXYLIC ACIDS HDHD5, ELOVL5, FASN EPHX1 1138/4885NAAA 20/4885HTT 4154/4885
US-12578648-B2 Rinsing liquid and pattern forming method ALKBH5, GABBR1, DNMT3B EPHX1 4065/4885NAAA 3630/4885HTT 3759/4885
US-20110118472-A1 Spiro Phosphine-Oxazoline, Preparation Method and Application thereof ADH1A, ADH1C, ALDH7A1 EPHX1 1278/4885NAAA 1651/4885HTT 4462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.